O'Leary, Ben
Finn, Richard S.
Turner, Nicholas C.
Article History
First Online: 31 March 2016
Competing interests
: N.C.T. is a member of the advisory boards of Lilly, Novartis and Pfizer. R.S.F. declares that he has acted as an advisor for Bayer Pharmaceuticals, Bristol–Myers Squibb, Novartis, and Pfizer, and has received research support from these companies via his institution. B.O. declares no competing interests.